Sunday, August 16, 2009

Looking back at the first quarter of 2009, we see how the year began with recession, this recession have certainly disturbed many top portfolios across the global corporate world. The recession had its toll on every area and every aspect. However we observe the least effect of renaissance is on the Pharma Industry and hence it gains the tag of bieng called the recession proof industry.

In this recession proof industry, clinical trials stood tall in this tough times without much major impact, now when there are signs in the global market of a complete recovery we need to understand the more significance this section of the market carries in store for one and all. MaxisIT bieng closely associated with clinical domain has gained complete expertise in providing complete range of clinical functional services to this industrial domain across the globe

Monday, August 3, 2009

METUCHEN, N.J.- Enterprise class software-suite CT Renaissance™ has won the Bio-IT World 2009 Best of show award under Clinical Trials and Research category. This award was presented at the Bio-IT World Conference and Expo ’09 held at Boston, MA on April 27 - 29. Companies like Phase Forward and IMC were among the finalists under the same category.

Judged by a team of Bio-IT World editors and highly regarded industry experts, the Best of Show Awards recognize products released or updated in the past 12 months that demonstrate exceptional technology innovations across the life sciences research, discovery, and clinical trials industries.

"Each year our exhibitors present the tools and solutions that are critical to driving the drug discovery and clinical industries forward," said Allison Proffitt, managing editor of Bio-IT World magazine. "There is a wealth of cutting edge and smart technologies for our judges to choose from, and we congratulate the 2009 Best of Show winners, and look forward to seeing how these new products enable and transform the industry."

Accepting the award on behalf of the entire team, Maulik Shah, VP – Global Sales and Delivery, said, “We are truly honored and very happy to have received this award and encouraged by the industry’s response to CT Renaissance™.”

MaxisIT’s CT Renaissance platform is an enterprise-class, most efficient, integrated, automated and web-based software solution suite that involves no IT footprint at point-of-use and is available at the most competitive investment that guarantees return.

As simple as using a web-based email account, this software-as-a-service oriented, internet solution helps MaxisIT’s small to large customers world-wide manage the pulse of their clinical trials and produce and manage clinical documents ranging from protocol to the eCTD – anytime, anywhere, on-demand.

About MaxisIT

MaxisIT is a premier enterprise-class clinical software and clinical functional services provider (FSP) that offers a unique blend of both, clinical trial domain and core IT expertise, with a thorough understanding of industry and regulatory standards.

MaxisIT’s CT Renaissance™ and clinical FSP enable its pharmaceutical and life sciences industry customers realize their vision of a safe, effective, and FDA approved delivery of drug at the lowest cost and at the fastest time to market. Our metrics for success include strategic enterprise-wide reusable and scalable solutions and world-class services team with industry’s best people, processes, technologies and a long-term partnering focus.

MaxisIT’s CT Renaissance™ is the most efficient, web-based, enterprise class software solution that involves no IT footprint at the point of use and is available at the most competitive investment that guarantees return.

Mr. Shah further added that CT Renaissance™ provides greater flexibility, scalability and ease of planning and managing clinical trials, monitoring drug safety, and producing clinical trial deliverables in a collaborative, yet globally distributed work-environment. He said that, “With the help of this software, our customers will achieve significant time and cost savings realized through standardized, streamlined and reusable infrastructure that requires minimum manual intervention. They will also be able to manage the pulse of their clinical trials in real-time and make competitive business decisions faster with the help of its built-in business process monitoring system.”

Utilizing industry standards such CDISC, hl7 and other XML based data standards, CT Renaissance™ promises to eliminate cumbersome and obsolete processes that impede timely production of deliverables. It can accommodate multiple trials in a parallel multi-user, role-based and secured environment.

Ashvee Kanwar, Director of Marketing at MaxisIT summarized, “We strongly believe that fully functional CT Renaissance™ will provide pharmaceutical businesses the power to grow, accelerating introduction of new drugs to the market and corresponding revenues, reduce overall research and development expenditures, enhance existing data quality control efforts, increase drug safety compliance and reduce clinical and economic risk.”

CT Renaissance™ Overview:

An Enterprise class platform

Web-based and services oriented

Faster deliverables with reduced manual interventions

Minimum or no IT footprint at point of use

Increased efficiency and reduced noise

Supports geographically distributed user base

Integrated and automated processes

Built-in business process monitoring system

Reduced time to market

Cost effective solution

About MaxisIT

MaxisIT is a premier enterprise-class clinical software and clinical functional services provider (FSP) that offers a unique blend of both, clinical trial domain and core IT expertise, with a thorough understanding of industry and regulatory standards.

MaxisIT’s CT Renaissance™ and clinical FSP enable its pharmaceutical and life sciences industry customers realize their vision of a safe, effective, and FDA approved delivery of drug at the lowest cost and at the fastest time to market. Our metrics for success include strategic enterprise-wide reusable and scalable solutions and world-class services team with industry’s best people, processes, technologies and a long-term partnering focus.